Developing vaccines and biologics for infectious diseases
Official title: Task V29: STORAGE OF GMP AND NON-GMP MATERIALS FOR NIAID
Funded at International AIDS Vaccine Initiative · NIH-10490543 · Data updated 2026-11-12
This study is working on creating new vaccines to help fight infectious diseases, including those that could come from bioterrorism, so that patients can have better protection and treatment options in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | International AIDS Vaccine Initiative NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | May 15, 2018 |
| Project end | May 14, 2028 |
| Funding year | 2021 |
| Award (this year) | $435,314 |
| NIH project number | 272201800010I-0-759302100001-2 |
| Project ID | NIH-10490543 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk for infectious diseases or those involved in clinical trials for new vaccines.
✕Less likely to help
Patients with non-infectious diseases or those not involved in the targeted clinical studies may not receive any benefit from this research.
What this research studies
This research focuses on providing essential services for the development of vaccines and biologics aimed at combating infectious diseases, including those that may arise from bioterrorism. It involves planning, feasibility assessments, and compliant manufacturing processes for clinical studies. The project also includes toxicology studies and regulatory support to ensure that new vaccines meet FDA standards. Patients may benefit from the advancements in vaccine technology and the introduction of new treatments for infectious diseases.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that protect against serious infectious diseases.
How similar studies have gone: Previous research has shown success in developing vaccines through similar methodologies, indicating a promising potential for this approach.
Where this research is happening
-
International AIDS Vaccine Initiative
New York, United States Active
Researchers
- Principal investigator: Hassel, Thomas — International AIDS Vaccine Initiative
- Study coordinator: Hassel, Thomas
Related research
Other NIH-funded projects on the same topics.
-
Creating vaccines for influenza and other infectious diseases
This study is all about creating new vaccines to help protect people from the flu and other infections, so patients can look forward to better options for staying healthy.
-
Developing vaccines and biologics for infectious diseases
This study is working on creating and improving vaccines to help protect people from infectious diseases like the flu and Nipah virus, so that patients can have better options for staying healthy.
-
Creating vaccines for human trials against influenza and other infectious diseases
This study is working on creating new vaccines to help protect people from flu and other infectious diseases, including those that could be used in harmful situations, so that everyone can have safer and more effective options to stay healthy.
-
Developing and producing new vaccines for infectious diseases.
This study is all about creating and testing new vaccines to help protect people from infectious diseases, including those that could come from bioterrorism or drug-resistant germs, so that patients can have better options for staying healthy.
-
New mRNA vaccines to prevent tuberculosis for adolescents and adults
A new mRNA vaccine approach aims to prevent TB in teens and adults and reduce transmission, using advanced vaccine technology.
-
New mRNA Vaccines for Tuberculosis
This research explores new mRNA vaccine technology to protect adolescents and adults from tuberculosis, a serious lung infection.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.